Author

H-R. Xu

Institutions: Peking University, Beijing Jishuitan Hospital

Observed institutions: Peking University, Beijing Jishuitan Hospital

OpenAlex ID: A5065535351

2690MO Extended efficacy and safety from the phase III MANEUVER trial of pimicotinib in patients with tenosynovial giant cell tumour (TGCT)

2025 · H. Gelderblom, V. Ravi, et al. · Annals of Oncology · 2

112P A single-arm, open, multicenter study to evaluate pegylated liposomal doxorubicin in the treatment of osteosarcoma

2023 · H-R. Xu, S. Wang, et al. · ESMO Open

Works count: 2

Citation count: 2

H-index: 1

I10-index: